Volume 78, Number 24, June 12, 2012
About this course
- Released: 06/11/2012
- Expires: 06/12/2014
Learning Objectives:
Upon completion of the article by Dodge et al, the participant should be able to:
• State clinical characteristics which differ at baseline between cognitively intact subjects and those with non-amnestic mild cognitive impairment (naMCI)
• Describe the likelihood of subjects being in the slow, moderate, or fast walker group depending upon cognitive status
• Discuss the relationship between cognitive status and trajectory over time of the coefficient of variation of walking speed
Core Competencies:
The article by Dodge et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Go et al, the participant should be able to:
• Discuss the evidence that corticosteroids other than adrenocorticotropic hormone (ACTH) are equal to ACTH in efficacy for the treatment of infantile spasms
• State the recommendation of this guideline regarding the use of low-dose versus high-dose ACTH
• Explain the conclusion regarding the comparative efficacy of ACTH and vigabatrin in treating infantile spasms
• Discuss the evidence that successful early treatment of infantile spasms leads to improved long-term outcomes
Core Competencies:
The article by Go et al covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
